BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8523515)

  • 1. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.
    Stubenrauch F; Leigh IM; Pfister H
    J Virol; 1996 Jan; 70(1):119-26. PubMed ID: 8523515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.
    Schmidt HM; Steger G; Pfister H
    J Virol; 1997 Oct; 71(10):8029-34. PubMed ID: 9311900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter.
    Stubenrauch F; Pfister H
    J Virol; 1994 Nov; 68(11):6959-66. PubMed ID: 7933077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
    Tan SH; Gloss B; Bernard HU
    Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor.
    May M; Grassmann K; Pfister H; Fuchs PG
    J Virol; 1994 Jun; 68(6):3612-9. PubMed ID: 8189499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
    Dong G; Broker TR; Chow LT
    J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
    Tan SH; Leong LE; Walker PA; Bernard HU
    J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2.
    Boeckle S; Pfister H; Steger G
    Virology; 2002 Feb; 293(1):103-17. PubMed ID: 11853404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
    Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; GarcĂ­a-Carranca A; Gariglio P
    Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
    Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
    J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region.
    Jackson ME; Campo MS
    J Virol; 1995 Oct; 69(10):6038-46. PubMed ID: 7666508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.
    Vance KW; Campo MS; Morgan IM
    J Virol; 2001 Mar; 75(6):2829-38. PubMed ID: 11222708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
    Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
    J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
    Thierry F; Howley PM
    New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
    Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
    Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB.
    Rank NM; Lambert PF
    J Virol; 1995 Oct; 69(10):6323-34. PubMed ID: 7666533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
    Steger G; Corbach S
    J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses.
    Giri I; Yaniv M
    J Virol; 1988 May; 62(5):1573-81. PubMed ID: 2833608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.
    Hiraiwa A; Kiyono T; Suzuki S; Ohashi M; Ishibashi M
    Virus Genes; 1996; 12(1):27-35. PubMed ID: 8879118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes.
    Stubenrauch F; Hummel M; Iftner T; Laimins LA
    J Virol; 2000 Feb; 74(3):1178-86. PubMed ID: 10627528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.